scholarly journals Well-Differentiated Lymphocytic Leukemia in a Dog: Long-Term Survival Without Therapy

1981 ◽  
Vol 18 (1) ◽  
pp. 37-47 ◽  
Author(s):  
J. W. Harvey ◽  
T. G. Terrell ◽  
D. M. Hyde ◽  
R. I. Jackson

Well-differentiated lymphocytic leukemia was found during routine hematologic examination of a 12-year-old female poodle with signs of anxiousness, panting and pica. The total white blood cell count was 106,900/μ1 and at least 90% of the leukocytes were small, normal-appearing lymphocytes. The dog was examined several times during a 23-month period before it was killed at the owner's request for conditions unrelated to the leukemia. The hematologic picture of the leukemia was essentially unchanged during this time. A deep nuclear cleft was seen in most lymphocytes examined by electron microscopy. Cell surface markers showed most blood lymphocytes to be B-cells. These cells responded poorly to mitogen stimulation.

2022 ◽  
Vol 8 ◽  
Author(s):  
Ga-Won Lee ◽  
Min-Hee Kang ◽  
Jin-Ha Jeon ◽  
Doo-Won Song ◽  
Woong-Bin Ro ◽  
...  

A 7-year-old castrated male Poodle dog presented with chronic progressive lymphocytosis. Hematologic and peripheral blood smear findings included remarkable lymphocytosis with well-differentiated small lymphocytes. Cytology of bone marrow aspirate showed hypercellular integrity with infiltration of small mature lymphocytes, accounting for 45% of all nucleated cells. Flow cytometry of blood and marrow samples revealed neoplastic lymphocytes predominantly expressing the CD21 molecule. B-cell chronic lymphocytic leukemia (CLL) was diagnosed on an immunophenotypic analysis. Administrations of prednisolone and chlorambucil were initiated and the response was unremarkable. Therefore, additional treatment with imatinib was provided, which resolved the hematologic abnormalities associated with CLL. Flow cytometry after ~1 year of treatment showed normalization of the count of lymphocytes positive for CD21 and resolved hematologic lymphocytosis. The dog was followed-up for 2 years, and there were no severe adverse effects. This case indicates that imatinib may be a good option as an adjunctive therapy with prednisolone and chlorambucil treatment for CLL in dogs without treatment response.


Haematologica ◽  
2017 ◽  
Vol 103 (4) ◽  
pp. e158-e161 ◽  
Author(s):  
Panagiotis Baliakas ◽  
Mattias Mattsson ◽  
Anastasia Hadzidimitriou ◽  
Eva Minga ◽  
Andreas Agathangelidis ◽  
...  

2020 ◽  
Vol 481-482 ◽  
pp. 112792
Author(s):  
Mariana Hugo Silva ◽  
Rico Lepzien ◽  
Sebastian Ols ◽  
Benita Dahlberg ◽  
Johan Grunewald ◽  
...  

1991 ◽  
Vol 418 (6) ◽  
pp. 551-556 ◽  
Author(s):  
M. Loda ◽  
A. E. Mendoza ◽  
C. O'Hara ◽  
J. M. Crawford ◽  
M. Federman ◽  
...  

Haigan ◽  
2003 ◽  
Vol 43 (1) ◽  
pp. 23-27
Author(s):  
Hiroyuki Oura ◽  
Mikihito Ishiki ◽  
Masahide Hirose ◽  
Nobukazu Tomichi ◽  
Kazuo Takayama ◽  
...  

2021 ◽  
Vol 10 (2) ◽  
pp. 139
Author(s):  
ShokhanMohammad Mustafa ◽  
AhmedKhudair Yassin ◽  
NawsherwanS Mohammed ◽  
RawandP Shamoon ◽  
MarwaN Karam ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document